Browse through our press and news section by category:

Mainz / Germany, 13 February 2013 –SCHOTT AG has experienced a strong demand for laboratory services related to so-called “extractables and leachables” (“E&L”) and therefore continued to expand this range of analyses offered to its customers. On the occasion of the international trade fair Pharmapack in Paris, the German group of companies today announced this extension of its services.

Extractables and leachables are substances, which can be dissolved and released from the constituent parts – glass, metals, rubber, lubricants, adhesives, etc. – of the packaging materials that form the container system. To determine any possible interactions with the drugs and exclude them, pharmacists are obliged to perform extensive studies. This procedure is mainly intended for the protection of patients. “Through our extended service offering, we are now able to support pharmaceutical even more efficiently in the assessment of risks”, said Dr. Uwe Rothhaar, Director of SCHOTT pharma services division.

SCHOTT pharma services remains on the Road to Success!

By strengthening the “Extractables & Leachables” range of analyses, SCHOTT pharma services underlines its position as an experienced partner for pharmacists who benefit not only from SCHOTT’s decades of expertise but also from a combination of laboratory services, which is unique in the market.

Since the SCHOTT group started to produce – as early as in 1911 – pharmaceutical containers made of glass and, at a later date, also commenced to manufacture pharmaceutical packagings such as ampoules, vials, cartridges and syringes, the company has built up comprehensive product and process know-how. Furthermore SCHOTT maintains a basic research center for glass by itself. This know-how and these professional skills have been pooled in the SCHOTT pharma services division and – since 2009 – have also been available to enterprises outside the group.

“An increasing number of drug manufacturers ask us to test their outer packages. The spectrum ranges from the analysis of interactions between drug and packaging materials to fracture and strength tests”, stated Rothhaar. His team offers a wide range of analytical services based on the modern instruments of a laboratory whose state of the art is ensured by continuous investments of SCHOTT. In addition, the resources of the central Research and Technology Development division of SCHOTT – located in the same building in Mainz as well as in Duryea, U.S. – can be called on as well. The entire laboratory as well as all lab operations and processes are accredited to DIN EN ISO 17025 and thus guarantee highest quality standards.

More informations about SCHOTT under pharma.services@schott.com, phone +49(0)6131/66-7339

Picture ID 192327: SCHOTT AG has experienced a strong demand for laboratory services related to so-called “extractables and leachables” (“E&L”) and therefore continued to expand this range of analyses offered to its customers. SCHOTT pharma services offers a wide range of analytical services based on the modern instruments of a laboratory whose state of the art is ensured by continuous investments of SCHOTT.

About SCHOTT
SCHOTT is an international technology group with more than 125 years of experience in the areas of specialty glasses and materials and advanced technologies. SCHOTT ranks number one in the world with many of its products. Its core markets are the household appliance, pharmaceuticals, electronics, optics, solar power, transportation and architecture industries. The company is strongly committed to contributing to its customers’ success and making SCHOTT an important part of people’s lives with high-quality products and intelligent solutions. SCHOTT is committed to managing its business in a sustainable manner and supporting its employees, society and the environment. The SCHOTT Group maintains close proximity to its customers with manufacturing and sales units in all major markets. Its workforce of around 17,000 employees generated worldwide sales of approximately 2.9 billion euros for the 2010/2011 fiscal year. SCHOTT AG, with its headquarters in Mainz (Germany) is owned by the Carl Zeiss Foundation.